Phlow
  • About
    • Who We Are
    • Our Impact
    • Leadership
    • Careers
  • CDMO
  • Product Portfolio
  • U.S. Facilities
    • Industrial Footprint
    • SAPIR™
  • News
  • Collaborate
Select Page

Governor Northam Announces AMPAC Fine Chemicals to Expand Petersburg Operation with $25 Million Investment, Adding 156 New Jobs

2021, Other News

Pharmaceutical manufacturer is a collaborator in new government-funded partnership to produce essential medications Source: Virginia Governor Ralph S. Northam PETERSBURG—Governor Ralph Northam today announced that AMPAC Fine Chemicals (AFC), a leading manufacturer of...

Shortages of Key Drugs for Children Spur New Hospital Coalition

2021, Other News

Source: Bloomberg In Washington, just four miles from the U.S. Capitol, a children’s hospital is forced at times to call up nearby medical centers to see if they can spare the therapies needed for its young cancer patients. In Chicago, a drug called epinephrine, which...

Leading Children’s Hospitals and Phlow Corp. Form an Unprecedented Coalition to Deliver Essential Medicines to Address Pediatric Drug Shortages

2021, Press Releases, Updates From Phlow™

RICHMOND, Va., March 18, 2021 – Phlow Corp., a U.S.-based, public benefit corporation committed to a bold mission of providing every American with access to affordable, high-quality essential medicines, today joins in announcing the launch of a groundbreaking...

Phlow Corp. and USP Announce Strategic Alliance Focused on Pharmaceutical Continuous Manufacturing to Increase Supply of Essential Medicines for U.S. Patients

2021, Press Releases, Updates From Phlow™

Source: BUSINESS WIRE RICHMOND, Va.– Phlow Corp., a public benefit essential medicines solutions provider, and the United States Pharmacopeia (USP) today announced a strategic alliance to develop a new laboratory that will certify and validate Pharmaceutical...

Phlow Corp. Closes $20 Million Series A Financing to Further Essential Medicines Research and Development Programs and Advanced Manufacturing Initiatives

2021, Press Releases, Updates From Phlow™

Pioneering essential medicines company seeks to actively accelerate U.S. manufacturing for medicines at risk of shortage, including those for COVID-19 pandemic response Source: BUSINESS WIRE RICHMOND, Va.– Phlow Corp., a public benefit corporation committed to a...
« Older Entries
Next Entries »

Recent Posts

  • Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System, Ushering in a New Era of Modern Medicine Manufacturing in America
  • Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America
  • JPEO-CBRND, in Partnership with HHS, Utilizes Interagency Agreement to Contract with Phlow Corporation to Provide Medical Countermeasures
  • Phlow Observes 4th Annual National Essential Medicine Shortage Awareness Day, Reaffirms Commitment to Protecting America’s Medicine Cabinet
  • Drug Ingredient Builder Phlow Becomes Operational in Petersburg

Recent Comments

No comments to show.

WHY THIS MATTERS
JOIN US

+1 (804) 207-4893

[email protected]

424 Hull St., Suite 400
Richmond, VA 23224

MEDIA INQUIRIES

STAY CONNECTED

  • Follow
  • Follow
  • Follow

To report an adverse event or product complaint associated with Phlow Drug Products, please call (844) 708-2982.

Privacy Policy | Consent Preferences | Additional Resources & Policies